Biogen Inc. : Buying pressure
Entry price | Target | Stop-loss | Potential |
---|
US$311.14 |
US$377 |
US$269 |
+21.17% |
---|
The recent break-out to the upside has created potential for further gains for shares in Biogen Inc..
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● The company has solid fundamentals for a short-term investment strategy.
Strengths● The group's activity appears highly profitable thanks to its outperforming net margins.
● Thanks to a sound financial situation, the firm has significant leeway for investment.
● Its low valuation, with P/E ratio at 8.52 and 9.14 for the ongoing fiscal year and 2021 respectively, makes the stock pretty attractive with regard to earnings multiples.
Weaknesses● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.